期刊文献+

复方丹参滴丸治疗冠心病随机平行对照研究 被引量:2

Compound Danshen Dripping Pills for Treating Coronary Heart Disease Study Random Parallel Control
原文传递
导出
摘要 [目的]观察复方丹参滴丸治疗冠心病疗效。[方法]使用随机平行对照方法,将105例住院及门诊患者按随机数字表法分为两组。对照组63例常规硝酸异山梨酯,5mg/次,3次/d,口服。治疗组42例复方丹参滴丸,270mg/次,3次/d,空腹口服(餐前或餐后>2小时)。连续治疗28d为1疗程,观测临床症状、不良反应。治疗1疗程,判定疗效。[结果]治疗组显效28例,有效10例,无效4例,总有效率90.48%。对照组显效17例,有效22例,无效24例,总有效率61.90%。治疗组疗效优于对照组(P<0.01)。[结论]复方丹参滴丸治疗冠心病效果显著,值得推广。 [Objective] To observe the curative effect of Compound Danshen dripping pills. [Methods] Using randomized controlled Methods,105 cases of inpatient and outpatient were randomly divided into two groups. 63 cases of the control group conventional isosorbide mononitrate,5mg/,3 /d,oral. The treatment group of 42 cases of Compound Danshen dripping pills,270mg/,3 /d,fasting oral(2 hour before or after meals.). Continuous treatment with 28d for 1 course of treatment,observation of clinical symptoms,adverse reaction. 1 courses of treatment,the curative effect. 28 cases of group therapy. [Results] 10 cases were effective,4 cases ineffective,the total efficiency of 90.48%. The control group was 17 cases,effective 22 cases,invalid 24 cases,the total efficiency of 61.90%. The treatment group was better than control group(P〈0.01). [Conclusion] The effect of Compound Danshen Dripping Pills in the treatment of coronary heart disease was significant,worthy of promotion.
作者 杨涛 王霞
出处 《实用中医内科杂志》 2014年第3期34-35,共2页 Journal of Practical Traditional Chinese Internal Medicine
关键词 冠心病 复方丹参滴丸 硝酸异山梨酯 随机平行对照研究 Coronary heart disease Compound Danshen dripping pills Isosorbide dinitrate Randomized parallel controlled study
  • 相关文献

参考文献3

二级参考文献10

  • 1顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:484
  • 2Tureci O, Sahin U, Schobert I, et al. The SSX-2 geae, which is involved in the t(X; 18) translocation of syno- vial sarcomas, codes for the human tumor antigen HOM-MEL-40[J]. Cancer Res, 1996,56 (20) : 4 766- 4 772.
  • 3Lim FL,Soulez M,Koczan D,et al. A KRA related do- main and a novel transcription repression domain in proteins encoded by SSX genes that ale disrupted in hu man sarcomas [J]. Oncogene, 1998, 17 ( 15):2 013- 2 018.
  • 4Wu LQ, Lu Y,Wang XF,et a|. Expression of cancer- testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma [J]. Life Scn, 2006,79(8): 744-748.
  • 5Valmori D, Qian F, Ayyoub M, et aL Expression of syn ovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T eells[J]. Clin Cancer Res,2006,12(2) :398- 404.
  • 6Atanackovie D, Arfsten J,Cao Y, et al. Cancer-testis an- tigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation[J]. Blood,2007,109(3) : 1 103-1 112.
  • 7Niemeyer P,Tureci O,Eberle T,et al. Expression of se rologically identified tumor antigens in acute leukemias [J]. Leuk Res,2003,27 :655-660.
  • 8Dubovsky JA,Albertini MR,McNeel DG. MAD-CT-2 identified as a novel melanoma cancer-testis antigen u- sing phage immunoblot analysis [J]. J Immunother, 2007,30(7) :675-683.
  • 9宁芳,何晓莲,才绍江.影响儿童急性淋巴细胞白血病化疗疗效及预后的分子生物学因素[J].中国小儿血液与肿瘤杂志,2009,14(5):238-240. 被引量:3
  • 10马占福,杨冬,贺福初,姜颖.KRAB型锌指蛋白在高等脊椎动物胚胎发育和肿瘤发生、发展中的调控功能[J].遗传,2010,32(5):431-436. 被引量:8

同被引文献97

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部